These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18283084)

  • 21. Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-2010).
    Liniker E; Harrison M; Weaver JM; Agrawal N; Chhabra A; Kingshott V; Bailey S; Eisen TG; Corrie PG
    Br J Cancer; 2013 Oct; 109(8):2051-7. PubMed ID: 24064969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional study.
    Moore TJ; Heyward J; Anderson G; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e038863. PubMed ID: 32532786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone graft substitutes for the treatment of traumatic fractures of the extremities.
    Hagen A; Gorenoi V; Schönermark MP
    GMS Health Technol Assess; 2012; 8():Doc04. PubMed ID: 22984371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative costs and activity from a sample of UK clinical trials units.
    Hind D; Reeves BC; Bathers S; Bray C; Corkhill A; Hayward C; Harper L; Napp V; Norrie J; Speed C; Tremain L; Keat N; Bradburn M
    Trials; 2017 May; 18(1):203. PubMed ID: 28464930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project.
    Beresniak A; Schmidt A; Proeve J; Bolanos E; Patel N; Ammour N; Sundgren M; Ericson M; Karakoyun T; Coorevits P; Kalra D; De Moor G; Dupont D
    Contemp Clin Trials; 2016 Jan; 46():85-91. PubMed ID: 26600286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Financial management of large, multi-center trials in a challenging funding milieu.
    Lovegreen O; Riggs D; Staten MA; Sheehan P; Pittas AG
    Trials; 2018 May; 19(1):267. PubMed ID: 29724229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving efficiency and reducing costs: Design of an adaptive, seamless, and enriched pragmatic efficacy trial of an online asthma management program.
    Lu M; Ownby DR; Zoratti E; Roblin D; Johnson D; Johnson CC; Joseph CL
    Contemp Clin Trials; 2014 May; 38(1):19-27. PubMed ID: 24607295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Difficulties with conducting clinical trials in France].
    Zannad F; Plétan Y
    Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multi-national clinical therapy studies. Design, management and costs].
    Demol P; Weihrauch TR
    Med Klin (Munich); 1997 Feb; 92(2):117-23. PubMed ID: 9139211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.
    Coffey CS; Levin B; Clark C; Timmerman C; Wittes J; Gilbert P; Harris S
    Clin Trials; 2012 Dec; 9(6):671-80. PubMed ID: 23250942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency.
    Nevens H; Harrison J; Vrijens F; Verleye L; Stocquart N; Marynen E; Hulstaert F
    Trials; 2019 Dec; 20(1):714. PubMed ID: 31829233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.
    Reed SD; Anstrom KJ; Bakhai A; Briggs AH; Califf RM; Cohen DJ; Drummond MF; Glick HA; Gnanasakthy A; Hlatky MA; O'Brien BJ; Torti FM; Tsiatis AA; Willan AR; Mark DB; Schulman KA
    Am Heart J; 2005 Mar; 149(3):434-43. PubMed ID: 15864231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal allocation of sample sizes to multicenter clinical trials.
    Lai D; Chang KC; Rahbar MH; Moye LA
    J Biopharm Stat; 2013; 23(4):818-28. PubMed ID: 23786227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prasugrel compared to clopidogrel in patients with acute coronary syndrome undergoing percutenaous coronary intervention: a Spanish model-based cost effectiveness analysis.
    Davies A; Sculpher M; Barrett A; Huete T; Sacristán JA; Dilla T
    Farm Hosp; 2013; 37(4):307-16. PubMed ID: 24010692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
    Mugford M; Hutton G; Fox-Rushby J
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.